03/12/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/12/2020. This 28-page rapid risk assessment details how all European Union/European Economic Area (EU/EEA) countries and the United Kingdom (UK) are affected by the COVID-19 (coronavirus) pandemic, reporting a total of 17,413 cases as of March 11, 2020. In the current situation where COVID-19 is rapidly spreading worldwide and the number of cases in Europe is rising with increasing pace in several affected areas, there is a need for immediate targeted action. The risk of transmission of COVID-19 in health and social institutions with large vulnerable populations is considered high. (PDF)
03/11/2020 12:00 AM EDT
Source: U.S. House of Representatives, Committee on Homeland Security. Published: 3/11/2020. This two-hour, seven-minute Congressional hearing features government witnesses who discuss the federal response to the coronavirus (COVID-19) and assess what more must be done to address this pandemic threat. They discuss steps to get the outbreak under control, including whether limiting mass gatherings, temporarily closing schools, or restricting certain travel may be necessary; and updates from the White House Coronavirus Task Force. (Video or Multimedia)
03/11/2020 12:00 AM EDT
Source: U.S. Government Accountability Office (GAO). Published: 3/11/2020. This 13-page Congressional testimony details how well the National Biodefense Strategy, issued in 2018 to address biological threats, has worked so far. Biological threats can be man-made biological weapons, naturally occurring diseases such as novel coronavirus (COVID-19), and more. The testimony highlights key findings from a February 2020 report that analyzed the extent to which the strategy and related implementation efforts are designed to allow an enterprise-wide approach, and made four recommendations aimed at improving the strategy’s implementation. (PDF)
03/11/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/11/2020. The potential for transmission of SARS-CoV-2, which causes COVID-19 (coronavirus) by blood and blood components is unknown at this time. This web page provides updated information for blood establishments regarding the novel coronavirus, and lists considerations and additional resources. (Text)
03/10/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/10/2020. This web page provides answers to frequently asked questions about water transmission and COVID-19. Topics include the possible spread of COVID-19 through drinking water, pools, hot tubs, and sewage systems; and the precautions wastewater workers should take to protect themselves. (Text)
03/10/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/10/2020. This web page provides frequently asked questions about COVID-19 (coronavirus disease) testing at laboratories. Topics include where public health laboratories can get access to testing kits to detect the COVID-19 virus, the International Reagent Resource (IRR), and where clinical and commercial laboratories can get access to testing supplies to detect the virus. (Text)
03/10/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/10/2020. This 10-page document provides a framework for actions which local and state health departments can recommend in their community to both prepare for and mitigate community transmission of COVID-19 (coronavirus disease) in the United States. Selection and implementation of these actions should be guided by the local characteristics of disease transmission, demographics, and public health and healthcare system capacity. (PDF)
03/10/2020 12:00 AM EDT
Source: Centers for Medicare and Medicaid Services (CMS). Published: 3/10/2020. This four-page memorandum clarifies the application of Centers for Medicare and Medicaid Service (CMS) policies in light of recent Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) guidance expanding the types of facemasks health care workers may use in situations involving COVID-19 (coronavirus) and other respiratory infections. With this announcement, health care workers in providers and suppliers certified by CMS will have a more expansive range of options to protect themselves and those receiving their care. (PDF)
03/09/2020 12:00 AM EDT
Source: Centers for Medicare and Medicaid Services (CMS). Published: 3/9/2020. This seven-page memorandum, updated on March 9, 2020, provides guidance to nursing homes to help control and prevent the spread of the 2019 coronavirus (COVID-19), in addition to general guidance already distributed. It also provides answers to frequently asked questions about some specific areas related to nursing homes and COVID-19. (PDF)
03/09/2020 12:00 AM EDT
Source: Centers for Medicare and Medicaid Services (CMS). Published: 3/9/2020. This seven-page memorandum responds to questions the Centers for Medicare and Medicaid has received, and provides important guidance for hospices (in-patient units, nursing facilities, assisted living, hospitals, and home settings) in addressing the COVID-19 (coronavirus) outbreak and minimizing transmission to other individuals. This guidance applies to both Medicare and Medicaid providers. (PDF)
03/09/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 3/9/2020. This 10-page document provides answers to frequently asked questions about diagnostic testing, which is a critical part of the public health response to and clinical management of COVID-19, caused by the SARS-CoV-2 virus. Topics include the kinds of diagnostic tests, and the Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel. (PDF)
03/01/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/2020. This 10-page document was written to support public health preparedness planning and response activities based upon social distancing measures aimed at minimizing the spread of COVID-19 (coronavirus). Social distancing is an action taken to minimize contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs) aimed at reducing disease transmission and thereby also reducing pressure on health services. (PDF)
02/01/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 2/2020. Risk communication is an integral component of public health risk management and a core capacity under the International Health Regulations. This 16-page document provides suggestions, principles, and templates that will be essential to ensure that people understand the risks of COVID-19 (coronavirus) and follow authorities’ recommendations to protect their health and the health of their loved ones. (PDF)
02/01/2020 12:00 AM EST
Source: Association of Public Health Laboratories (APHL). Published: 2/2020. Public health laboratories must have in place a continuity of operations plan (COOP). This 18-page report describes how all but three state laboratories have a COOP, but the extent to which they have tested their COOP varies. The Association of Public Health Laboratories (APHL) contracted with the RAND Corporation to build upon RAND’s past work to update the previously developed tabletop exercise and pilot test it in four laboratories. The report reviews plans, provides an overview of a tabletop exercise, and reports findings from the pilot test and next steps. (PDF)
07/01/2019 12:00 AM EDT
Source: World Health Organization (WHO). Published: 7/2019. This 26-page paper provides an overview of the impacts of climate variability and change on sanitation and the implications for health. It outlines potential adaptation options for strengthening climate resilience of sanitation governance, policies, systems, and services, and highlights further research needs and imperatives for policy and programming. It has a global focus, noting that the specific issues may differ across countries with varying levels of onsite and sewerage sanitation systems. (PDF)
.png)
No hay comentarios:
Publicar un comentario